AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26520218 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Triple P Program with additional father‐relevant content
Number of subjects: 42
Study 26520218 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 42
Study 24570981 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mm long and 4 mm wide implants
Number of subjects: 40
Study 24570981 — intervention group
Group type: COMPARATOR
Intervention: Implants at least 10 mm long in augmented bone
Number of subjects: 40
Study 24570981 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mm long implants
Number of subjects: 40
Study 21742400 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT), administered twice per week for a total of six treatments.
Number of subjects: 77
Study 21742400 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric oxygen therapy (HBOT), administered daily for a total of 20 treatments.
Number of subjects: 77
Study 19520125 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectations confirmed about food and emotion with positive mood induction
Number of subjects: 73
Study 19520125 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectations disconfirmed about food and emotion with negative mood induction
Number of subjects: 73
Study 19520125 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive mood induction
Number of subjects: 73
Study 19520125 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mood induction
Number of subjects: 73
Study 19520125 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 73
Study 16772765 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg celecoxib twice a day
Number of subjects: 10
Study 16772765 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg acetazolamide twice a day
Number of subjects: 10
Study 16772765 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice a day
Number of subjects: 10
Study 15309644 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydropneumatic anal dilation (HAD)
Number of subjects: 109
Study 15309644 — intervention group
Group type: COMPARATOR
Intervention: Topical nitroglycerin (GTN)
Number of subjects: 109
Study 11904978 — intervention group
Group type: EXPERIMENTAL
Intervention: rhuMAb‐E25 (recombinant humanized monoclonal anti‐IgE antibody)
Number of subjects: 0
Study 9818888 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimigraine therapy
Number of subjects: 42
Study 9818888 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin ointment test
Number of subjects: 42
Study 7622802 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg remoxipride
Number of subjects: 36
Study 7622802 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg haloperidol
Number of subjects: 36
Study 7622802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 1978501 — intervention group
Group type: EXPERIMENTAL
Intervention: Remoxipride
Number of subjects: 92
Study 1978501 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 92
Study 606774 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-virus vaccines
Number of subjects: 110
Study 606774 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-product vaccines
Number of subjects: 110
Study 606774 — intervention group
Group type: COMPARATOR
Intervention: Whole-virus vaccines and split-product vaccines
Number of subjects: 110
Study 606774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 7081917 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction drainage
Number of subjects: 0
Study 7081917 — intervention group
Group type: COMPARATOR
Intervention: Simple tube drainage
Number of subjects: 0
Study 7081917 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 0
Study 29096584 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine psychotherapy
Number of subjects: 9895
Study 29096584 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine psychotherapy for clients with initial severity similar to RCT participants
Number of subjects: 9895
Study 29096584 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine psychotherapy for moderately distressed clients
Number of subjects: 9895
Study 29096584 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine psychotherapy for severely distressed clients
Number of subjects: 9895
Study 28795452 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (chest and leg press exercises, three sets, eight repetitions, 80% predicted one-repetition maximum)
Number of subjects: 43
Study 28795452 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 43
Study 26722141 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-visit group
Number of subjects: 182
Study 26722141 — intervention group
Group type: COMPARATOR
Intervention: Telephone follow-up group
Number of subjects: 182
Study 26722141 — intervention group
Group type: COMPARATOR
Intervention: As-usual care group
Number of subjects: 182
Study 25104523 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG plus medical therapy
Number of subjects: 1212
Study 25104523 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT) alone
Number of subjects: 1212
Study 22800663 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-M + C
Number of subjects: 108
Study 22800663 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-M + C + P
Number of subjects: 108
Study 22800663 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-M
Number of subjects: 108
Study 22800663 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-P
Number of subjects: 108
Study 22800663 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-C
Number of subjects: 108
Study 22800663 — intervention group
Group type: EXPERIMENTAL
Intervention: M + C
Number of subjects: 108
Study 22800663 — intervention group
Group type: EXPERIMENTAL
Intervention: M + P
Number of subjects: 108
Study 22800663 — intervention group
Group type: EXPERIMENTAL
Intervention: M + C + P
Number of subjects: 108
Study 20598849 — intervention group
Group type: EXPERIMENTAL
Intervention: ATP infusions (50 μg/kg.minute, 8-10 hours/week for eight weeks)
Number of subjects: 99
Study 20598849 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ATP)
Number of subjects: 99
Study 18060956 — intervention group
Group type: EXPERIMENTAL
Intervention: Backfill-assisted voiding trial
Number of subjects: 60
Study 18060956 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous voiding trial
Number of subjects: 60
Study 15598450 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal knees
Number of subjects: 15
Study 15598450 — intervention group
Group type: COMPARATOR
Intervention: ACLD knees
Number of subjects: 15
Study 12052458 — intervention group
Group type: EXPERIMENTAL
Intervention: Fed state (breakfast at 08:00 h)
Number of subjects: 20
Study 12052458 — intervention group
Group type: COMPARATOR
Intervention: Fasting state (no breakfast)
Number of subjects: 20
Study 10431463 — intervention group
Group type: EXPERIMENTAL
Intervention: Markov model with minimum order
Number of subjects: 7
Study 10431463 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate, pNN30, and LF/HF index plots
Number of subjects: 7
Study 7769367 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic hormone (ANH) at low dose (0.6 pmol/kg/min)
Number of subjects: 11
Study 7769367 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic hormone (ANH) at medium dose (1.8 pmol/kg/min)
Number of subjects: 11
Study 7769367 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic hormone (ANH) at high dose (5.4 pmol/kg/min)
Number of subjects: 11
Study 7769367 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 11
Study 2178657 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 19
Study 2178657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 7021452 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutroline 20 mg daily
Number of subjects: 25
Study 7021452 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutroline 100 mg daily
Number of subjects: 25
Study 7021452 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutroline 1 mg daily
Number of subjects: 25
Study 30830974 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT assessment of T category
Number of subjects: 19
Study 30830974 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT assessment of N category
Number of subjects: 19
Study 30830974 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT assessment of M category
Number of subjects: 19
Study 30830974 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT assessment of resectability
Number of subjects: 19
Study 30830974 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT treatment allocation agreement
Number of subjects: 19
Study 30830974 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT treatment allocation agreement (Krippendorff's α)
Number of subjects: 19
Study 30830974 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT treatment allocation where resectability assessments were concordant
Number of subjects: 19
Study 28748412 — intervention group
Group type: EXPERIMENTAL
Intervention: DFN-15 120 mg
Number of subjects: 16
Study 28748412 — intervention group
Group type: EXPERIMENTAL
Intervention: DFN-15 180 mg
Number of subjects: 16
Study 28748412 — intervention group
Group type: EXPERIMENTAL
Intervention: DFN-15 240 mg
Number of subjects: 16
Study 28748412 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 400-mg oral capsules
Number of subjects: 16
Study 23417765 — intervention group
Group type: EXPERIMENTAL
Intervention: Blonanserin under fasting (single dose 4, 8, and 12 mg)
Number of subjects: 50
Study 23417765 — intervention group
Group type: EXPERIMENTAL
Intervention: Blonanserin under food intake (single dose 8 mg)
Number of subjects: 50
Study 21236333 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (500mg twice per day)
Number of subjects: 0
Study 18783388 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand treatment with esomeprazole 20 mg
Number of subjects: 991
Study 18783388 — intervention group
Group type: COMPARATOR
Intervention: Continuous treatment with esomeprazole 20 mg once a day
Number of subjects: 991
Study 18229542 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked practice group
Number of subjects: 0
Study 18229542 — intervention group
Group type: EXPERIMENTAL
Intervention: Random practice group
Number of subjects: 0
Study 18229542 — intervention group
Group type: EXPERIMENTAL
Intervention: Random-blocked practice group
Number of subjects: 0
Study 18229542 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 14762056 — intervention group
Group type: EXPERIMENTAL
Intervention: Stavudine and Didanosine
Number of subjects: 21
Study 14762056 — intervention group
Group type: EXPERIMENTAL
Intervention: Stavudine, Didanosine and Hydroxyurea
Number of subjects: 21
Study 11713439 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (0.3 mg/kg/wk)
Number of subjects: 19
Study 9135362 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 MAC of isoflurane with 50% nitrous oxide
Number of subjects: 10
Study 9135362 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 MAC of isoflurane with 50% nitrous oxide
Number of subjects: 10
Study 9135362 — intervention group
Group type: COMPARATOR
Intervention: 1.0 MAC of isoflurane alone
Number of subjects: 10
Study 8422091 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone-releasing factor (GH-RF)
Number of subjects: 13
Study 8422091 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 13
Study 8422091 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 13
Study 3630291 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase short-term lysis
Number of subjects: 50
Study 3630291 — intervention group
Group type: COMPARATOR
Intervention: Conventional heparin phenprocoumon treatment
Number of subjects: 50
Study 3630291 — intervention group
Group type: COMPARATOR
Intervention: Control group (without fibrinolysis)
Number of subjects: 50
Study 3630291 — intervention group
Group type: EXPERIMENTAL
Intervention: Early lysis (within 4 hours)
Number of subjects: 50
Study 3630291 — intervention group
Group type: EXPERIMENTAL
Intervention: Late lysis (4-6 hours)
Number of subjects: 50
Study 30753101 — intervention group
Group type: EXPERIMENTAL
Intervention: SynGEM (low dose: 140 μg F, 2 mg BLP)
Number of subjects: 48
Study 30753101 — intervention group
Group type: EXPERIMENTAL
Intervention: SynGEM (high dose: 350 μg F, 5 mg BLP)
Number of subjects: 48
Study 30753101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 30753101 — intervention group
Group type: EXPERIMENTAL
Intervention: SynGEM (both doses)
Number of subjects: 48
Study 30753101 — intervention group
Group type: EXPERIMENTAL
Intervention: SynGEM
Number of subjects: 48
Study 28228134 — intervention group
Group type: EXPERIMENTAL
Intervention: ART home delivery by community health workers (CHWs)
Number of subjects: 48
Study 28228134 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (facility-based ART and CHW home visits without ART home delivery)
Number of subjects: 48
Study 25382428 — intervention group
Group type: EXPERIMENTAL
Intervention: Open‐fit hearing aids with the built‐in receiver unit (receiver in the ear)
Number of subjects: 20
Study 25382428 — intervention group
Group type: COMPARATOR
Intervention: Open‐fit hearing aids with RITE
Number of subjects: 20
Study 24091921 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling (Promoting Resilience in Mothers' Emotions)
Number of subjects: 262
Study 24091921 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting support
Number of subjects: 262
Study 22286619 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 89
Study 19192578 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpowder with manual toothbrush
Number of subjects: 36
Study 19192578 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpowder with finger
Number of subjects: 36
Study 19192578 — intervention group
Group type: COMPARATOR
Intervention: Toothpaste with manual toothbrush
Number of subjects: 36
Study 19192578 — intervention group
Group type: COMPARATOR
Intervention: Toothpaste with finger
Number of subjects: 36
Study 17041323 — intervention group
Group type: EXPERIMENTAL
Intervention: lathe‐cut contact lenses (lathe‐cut CL)
Number of subjects: 28
Study 17041323 — intervention group
Group type: EXPERIMENTAL
Intervention: cast‐molded contact lenses (cast‐molded CL)
Number of subjects: 28
Study 17041323 — intervention group
Group type: EXPERIMENTAL
Intervention: spun‐cast contact lenses (spun‐cast CL)
Number of subjects: 28
Study 17041323 — intervention group
Group type: COMPARATOR
Intervention: non‐CL
Number of subjects: 28
Study 12547950 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colposuspension
Number of subjects: 90
Study 12547950 — intervention group
Group type: COMPARATOR
Intervention: Open colposuspension
Number of subjects: 90
Study 10928526 — intervention group
Group type: EXPERIMENTAL
Intervention: CT fluoroscopy (CTF)
Number of subjects: 190
Study 10928526 — intervention group
Group type: COMPARATOR
Intervention: Classic CT-guided procedure (Control)
Number of subjects: 190
Study 8603242 — intervention group
Group type: EXPERIMENTAL
Intervention: Human corticotropin-releasing factor (hCRF) at doses of 2, 4, and 8 mu g/kg body weight
Number of subjects: 32
Study 8603242 — intervention group
Group type: EXPERIMENTAL
Intervention: Human corticotropin-releasing factor (hCRF) at 8 mu g/kg
Number of subjects: 32
Study 8603242 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 32
Study 1394808 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial administration of methotrexate (MTX), Adriamycin (ADM), and cisplatin (CDDP; IA-MAC)
Number of subjects: 48
Study 6372133 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination inhaler containing salbutamol and beclomethasone dipropionate
Number of subjects: 15
Study 6372133 — intervention group
Group type: COMPARATOR
Intervention: Two separate inhalers containing salbutamol and beclomethasone dipropionate
Number of subjects: 15
Study 6372133 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination inhaler
Number of subjects: 15
Study 6372133 — intervention group
Group type: COMPARATOR
Intervention: Separate inhalers
Number of subjects: 15
Study 31231970 — intervention group
Group type: EXPERIMENTAL
Intervention: Support provision from one partner
Number of subjects: 338
Study 31231970 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable levels of support provision and self-efficacy
Number of subjects: 338
Study 31231970 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-varying self-efficacy
Number of subjects: 338
Study 31231970 — intervention group
Group type: EXPERIMENTAL
Intervention: Lagged association
Number of subjects: 338
Study 30076800 — intervention group
Group type: EXPERIMENTAL
Intervention: REMOTE-CR (12 weeks of individualized exercise prescription, real-time physiological monitoring, coaching, and behavioral support)
Number of subjects: 162
Study 30076800 — intervention group
Group type: EXPERIMENTAL
Intervention: REMOTE-CR
Number of subjects: 162
Study 25939017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral training (CBT)
Number of subjects: 183
Study 25939017 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training (RT)
Number of subjects: 183
Study 25939017 — intervention group
Group type: COMPARATOR
Intervention: Health education (HE)
Number of subjects: 183
Study 23680034 — intervention group
Group type: EXPERIMENTAL
Intervention: Helical tomotherapy (HT) for whole-brain irradiation (WBRT) with integrated boost (IB)
Number of subjects: 23
Study 21368391 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic aerobic training (10-30 minutes of stationary cycling, 3 times a week for 8 weeks)
Number of subjects: 28
Study 21368391 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aerobic training)
Number of subjects: 28
Study 19357525 — intervention group
Group type: EXPERIMENTAL
Intervention: L-acetylcarnitine + BCAA
Number of subjects: 48
Study 19357525 — intervention group
Group type: COMPARATOR
Intervention: BCAA
Number of subjects: 48
Study 16872787 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention with booster dose
Number of subjects: 657
Study 16872787 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention without booster dose
Number of subjects: 657
Study 16872787 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 657
Study 15159241 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (4.5 g/d during the first 4 months of lactation)
Number of subjects: 105
Study 15159241 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein intake (measured as a percentage of energy)
Number of subjects: 105
Study 15159241 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein intake (measured as g/d)
Number of subjects: 105
Study 11300751 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltenac gel 1%
Number of subjects: 237
Study 11300751 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 237
Study 8184210 — intervention group
Group type: EXPERIMENTAL
Intervention: Right hemisphere teaching condition
Number of subjects: 0
Study 8184210 — intervention group
Group type: EXPERIMENTAL
Intervention: Interhemispherical teaching condition
Number of subjects: 0
Study 8184210 — intervention group
Group type: COMPARATOR
Intervention: Left hemisphere teaching condition
Number of subjects: 0
Study 3098772 — intervention group
Group type: EXPERIMENTAL
Intervention: 33 micrograms hCRH
Number of subjects: 12
Study 3098772 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms hCRH
Number of subjects: 12
Study 3098772 — intervention group
Group type: EXPERIMENTAL
Intervention: 67 micrograms hCRH
Number of subjects: 12
Study 30385884 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex‐PRESS implantation
Number of subjects: 64
Study 30385884 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 64
Study 28495462 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐based Cognitive Behaviour Therapy (ICBT), n=127
Number of subjects: 258
Study 28495462 — intervention group
Group type: COMPARATOR
Intervention: Standard care (face‐to‐face counselling), n=131
Number of subjects: 258
Study 28495462 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐based Cognitive Behaviour Therapy (ICBT)
Number of subjects: 258
Study 28495462 — intervention group
Group type: COMPARATOR
Intervention: Standard care (face‐to‐face counselling)
Number of subjects: 258
Study 28495462 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 258
Study 26376918 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheotomy tube open with no inner cannula
Number of subjects: 10
Study 26376918 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheotomy tube with Blom valve
Number of subjects: 10
Study 26376918 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheotomy tube with Passy-Muir valve
Number of subjects: 10
Study 24280079 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote telemonitoring using the Medtronic CareLink Network
Number of subjects: 200
Study 24280079 — intervention group
Group type: COMPARATOR
Intervention: Traditional face-to-face follow-up
Number of subjects: 200
Study 24280079 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote telemonitoring
Number of subjects: 200
Study 20843737 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF) training
Number of subjects: 0
Study 20843737 — intervention group
Group type: COMPARATOR
Intervention: Computerized attention skills training (Control)
Number of subjects: 0
Study 19058686 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-curing composite
Number of subjects: 34
Study 19058686 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-cured resin composites
Number of subjects: 34
Study 19058686 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall restorations
Number of subjects: 34
Study 19058686 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall clinical outcomes
Number of subjects: 34
Study 16552194 — intervention group
Group type: EXPERIMENTAL
Intervention: Intergel treatment (0.5% ferric hyaluronate gel)
Number of subjects: 32